India should review its regulation of new therapeutic paths enabled by tech advances. Think of AI and the wonders of Crispr gene editing. Safe ways exist to test modern therapies in a country that’s well placed to make breakthroughs.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.